⌘K

Home/Filings/4/0001415889-24-023147

4//SEC Filing

Curley Joanne 4

Accession 0001415889-24-023147

CIK 0001411685other

View on SEC.gov Company Profile

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 5:00 PM ET

Size

5.9 KB

Accession

0001415889-24-023147

Insider Transaction Report

Form 4

Period: 2024-09-06

Vistagen Therapeutics, Inc.VTGN

Director

Transactions

Award
Stock Option (Right to Buy)
2024-09-06+14,100→ 14,100 total
Exercise: $3.25Exp: 2034-09-06→ Common Stock (14,100 underlying)

Footnotes (1)

[F1]Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date.

Documents

1 file

4
form4-09102024_050907.xmlPrimary

Issuer

Vistagen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1

filerCIK 0001857670

Filing Metadata

Form type: 4
Filed: Sep 9, 8:00 PM ET
Accepted: Sep 10, 5:00 PM ET
Size: 5.9 KB

View on SEC.gov